AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06790212 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine，1000mg/m2，po，BID，D1-D14，Q3W
Study NCT05099380 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: senofilcon A C3
Description: TEST Lens
Study NCT05099380 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: senofilcon A
Description: CONTROL Lens
Study NCT05445739 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The effect of an online exercise course on the increase of elders' regular exercise intention
Description: The intervention of an online exercise course which 2 days a week for 4 weeks to increase the elders' regular exercise intention.
Study NCT05136703 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)
Description: CBT-AD is a behavioral intervention administered either in person or via Zoom. Each session lasts approximately 50 minutes. Participants will receive up to 12 individually delivered sessions over 4 months. Participants receive up to three individually delivered booster sessions through 6 months.
Study NCT06790212 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Capecitabine，1000mg/m2，po，BID，D1-D14，Q3W
Study NCT06789068 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lactose free regimen
Description: lactose free formula and solid foods that lack lactose for infants above 6 months, ensuring adequate macro and micronutrients intake according to recommended daily allowances (RDA) for age and sex.
Study NCT06280846 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high-intensity laser acupuncture and Exercise therapy program
Description: The patients will receive high-intensity lasers and the treatment will be performed at 15 acupuncture points: unilateral GV3, GV4, and GV5, and bilateral BL 20, BL23, BL24, BL25, BL40 and GB30.~Exercise therapy program: The patients will perform an exercise therapy program in the form of:~- strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises
Study NCT05136703 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Antiretroviral Therapy (ART) Adherence Counseling
Description: This treatment involves a single session integrating CBT for depression with CBT for adherence following our Life-Steps approach.
Study NCT04932837 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood and Saliva collection
Description: Serological, viral RNA and antigenic test
Study NCT05004116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Repotrectinib
Description: TPX-0005 (Repotrectinib) will be taken orally twice daily in 28-day cycles without regard to food and will be administered orally before administration of irinotecan and temozolomide (exception: C1, TPX-0005 (Repotrectinib) will be administered once daily x 14 days, then twice daily D15-D28).
Study NCT05004116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan and temozolomide
Description: Irinotecan and temozolomide will be given as per institutional standard.
Study NCT04466553 — intervention group
Intervention type: DEVICE
Intervention: NICO BrainPath™ System
Description: Patients who are admitted under the neurology service in the Neurocritical Care and Medical ICU will be screened for participation in the trial by their treating physician. Once blood pressure has been stabilized and the best medical treatment has been determined, the patient will need to undergo a standard of care, repeat CT scan 6 hours after stabilization to show that there has been no increase in size of the ICH. Patients that meet eligibility criteria after this CT will be taken to the OR within 24-72 hours for a minimally invasive, navigation guided endoport based evacuation of the clot using the NICO BrainPath™ system.
Study NCT06558669 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fresh Sugarcane juice
Description: Fresh sugarcane juice in different doses will be given to liver patients for 90 days
Study NCT06524479 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SEEG recording and CCEP
Description: This study aims to utilize the clinical, imaging, and electrophysiological data of patients with drug-resistant epilepsy. By Performing CCEP detection at specific targets during both wakefulness and sleep and analyzing its electrophysiological characteristics, the study will compare the functional properties of white matter fibers during wakefulness and sleep.
Study NCT06350955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside
Description: single dose of 500 mg iron isomaltoside
Study NCT06350955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron Carboxymaltose
Description: single dose of 500 mg ferric carboxymaltose
Study NCT05644587 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: buprenorphine/naloxone
Description: Buprenorphine/naloxone will be used to begin each patient's treatment for opioid use disorder.
Study NCT06280846 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-intensity laser acupuncture and Exercise therapy program
Description: The patients will receive low-intensity lasers and the treatment will be performed at 15 acupuncture points: unilateral GV3, GV4, and GV5, and bilateral BL 20, BL23, BL24, BL25, BL40 and GB30.~Exercise therapy program: The patients will perform an exercise therapy program in the form of:~- strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises
Study NCT06280846 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham laser acupuncture
Description: Sham laser acupuncture and exercise therapy program. The patients will receive a sham laser.acupuncture and an exercise therapy program in the form of: - strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises
Study NCT06789640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Vitamin C will be given before admission in the immediate preoperative preceding 7 days (the dose 30 -45 mg per day ) in oral drops preparations~Inflammatory markers including CRP , TLC ,PNI , GPS NLR will be checked on admission and on discharge and compared between cases and controls Hospital length stay will also be compared between the two groups
Study NCT06789640 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be given before admission in the immediate preoperative preceding 7 days (the dose 30 -45 mg per day ) in oral drops preparations~Inflammatory markers including CRP , TLC ,PNI , GPS NLR will be checked on admission and on discharge and compared between cases and controls
Study NCT04514757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active tVNS
Description: 20 Hz, 250ms at a current just below discomfort threshold for one hour twice a day, starting on post-day 0. Stimulation will continue until 5 days post-operatively or discharge.
Study NCT04514757 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tVNS
Description: Current set a 0 mA, starting on post-op day 0. Stimulation will continue until 5 days post-operatively or discharge.
Study NCT06469671 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The system based on real - time artificial intelligence - assisted for colonoscopy
Description: Russian medical decision support system based on artificial intelligence ArtInCol
Study NCT06469671 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: The system based on real - time artificial intelligence - assisted for colonoscopy
Description: Russian medical decision support system based on artificial intelligence ArtInCol
Study NCT04866524 — intervention group
Intervention type: OTHER
Intervention: Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3
Description: Ages \& Stages Questionnaires®, Third Edition (ASQ®-3) is a developmental screening tool designed for use by early educators and health care professionals. It relies on parents as experts, is easy to use, family-friendly and creates the snapshot needed to catch delays and celebrate milestones.
Study NCT04866524 — intervention group
Intervention type: OTHER
Intervention: Physical development and General Health
Description: Physical development and General health examination
Study NCT04866524 — intervention group
Intervention type: OTHER
Intervention: Developmental Red flags
Description: Developmental Red flags Questionnaires
Study NCT06788262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral MRI
Description: Cerebral MRI
Study NCT06788262 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cerebral MRI
Description: Cerebral MRI
Study NCT06789094 — intervention group
Intervention type: OTHER
Intervention: Ain Shams University Cognitive Assessment (ASCA) tool
Description: The ASCA, developed at Ain Shams University, is a comprehensive tool designed for cognitive assessment in Egyptian population. It encompasses various tests to assess cognitive functions and cultural understanding. These include the Verbal Paired Associated Test, evaluating verbal learning, distractor interval, delayed recall, and word recognition. The Bender Gestalt assesses visual-motor skills and memory. Short-term and working memory are tested through Digit Forward and Digit Backward Span Length tasks. Set Shifting is measured using a modified Trail Making Test, adapted for illiterates. Additionally, tests for letter/lexical fluency, verbal fluency, language object naming, abstraction, and judgment offer further insights into cognitive abilities and cultural interpretation.
Study NCT06788639 — intervention group
Intervention type: BIOLOGICAL
Intervention: Lisocabtagene maraleucel
Description: According to the United States Prescribing Information
Study NCT06788236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVTR101
Description: three times daily
Study NCT06788236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: three times daily
Study NCT06789575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: the patients will receive the content of a syringe (10 ml of bupivacaine 0.25%)
Study NCT06789575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adrenaline
Description: the patients will receive the content of a syringe 15 μg adrenaline
Study NCT06789575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine (drug)
Description: the patients will receive the content of a syringe 70 ml Lidocaine .
Study NCT04062344 — intervention group
Intervention type: OTHER
Intervention: Swab
Description: Rectal swab before and after the drug provocation testing
Study NCT06789250 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy
Description: The intervention within this study is based on cognitive behavioral therapy principles and adapted to target harmful alcohol use and mild to moderate alcohol use disorder co-occuring with psychological symptoms of depression, anxiety, stress and/or sleeping disorder. The 10 weeks of individually tailored treatment include psycho-educational texts as well as examples and exercises supported by a therapist.
Study NCT06789614 — intervention group
Intervention type: DRUG
Intervention: intravenous CYCLIZINE ,Metaclopromide
Description: US giuded measure of GRV in bariatrics surgery upon recieving drugs of study
Study NCT06789146 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus posterior superior intercostal plane block
Description: Serratus posterior superior intercostal plane block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance.~Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Study NCT06789146 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Paravertebral Block
Description: Thoracic paravertebral block will be performed on the patients using 30 ml of 0.25% bupivacaine under ultrasound guidance.~Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Study NCT06789289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQC2938 injection
Description: TQC2938 is a humanized monoclonal antibody that interfering with the signal cascade.
Study NCT06789289 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQC2938 injection Placebo
Description: TQC2938 is a humanized monoclonal antibody that interfering with the signal cascade.
Study NCT06790082 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-FAPI-46 PET/CT
Description: Patients with suspected pleural mesothelioma undergo FAPI PET/CT in addition to conventional imaging at primary staging.~The subgroup of patients undergoing anticancer treatment will undergo an additional FAPI PET/CT and FDG PET/CT after completing 2-3 series of anticancer treatment.
Study NCT06789939 — intervention group
Intervention type: OTHER
Intervention: Train the trainer program for MPCC professionals
Description: The intervention will consist on a train the trainer program. 3 professionals from each MPCC will be trained by an educational team. They will then have to implement an IPEP (knowledge of the MPCC, participation in interprofessional MPCC activities, etc.) for students on placement in their MPCC.
Study NCT06788886 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06788886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Intervention
Description: Participate in walking routines
Study NCT06788886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Intervention
Description: Participate in walking routines
Study NCT06788886 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06788886 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05389722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-92480
Description: Specified dose on specified days
Study NCT05389722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Specified dose on specified days
Study NCT05389722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Specified dose on specified days
Study NCT05389722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Specified dose on specified days
Study NCT05389722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Specified dose on specified days
Study NCT06041945 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard, high-definition colonoscopy with the use of CADe assistance
Description: All detected polyps regardless of size and optical diagnosis will be resected and sent to pathology.
Study NCT06041945 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard, high-definition colonoscopy with the use of CADe/CADx assistance, no leave-in-situ
Description: All detected polyps regardless of size and optical diagnosis will be resected and sent to pathology.
Study NCT06041945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard, high-definition colonoscopy with the use of CADe/CADx assistance, leave-in-situ
Description: Polyps will be left in situ if diminutive (≤5 mm) in size, located in the rectum or sigma and optically diagnosed by the endoscopist using the system to be hyperplastic with high confidence, otherwise resected and sent to pathology.
Study NCT06199219 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sexual counseling, based on the extended (EX-PLISSIT)
Description: The EX-PLISSIT model is done in a cyclical manner. In other words, it is an interactive and repetitive model. All interventions must begin with Permission. Each stage of Limited Information, Special Recommendation and Intensive Therapy is supported by Allowing. Thus, the interaction between counselors and clients is improved (Taylor and Davis 2006; Punjani and Papathanasoglu, 2019).
Study NCT06415045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1015550
Description: BI 1015550
Study NCT06788886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06191094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Faricimab Injection
Description: Pre-operative injection of bevacizumab appears to have mixed results in lowering post-operative vitreous hemorrhage. One potential reason is due to aspiration and removal of medication in the vitreous humor at the time of pars plana vitrectomy leading to less than anticipated results in controlling neovascularization and vitreous hemorrhage post-operatively. To avoid attenuation of our desired effect we plan to repeat faricimab injection post-operatively around week one.
Study NCT06191094 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: sham treatment
Description: Patients will be randomized 2:1 to receive either faricimab (6 mg from 0.05 mL of a 120 mg/mL) or sham injection
Study NCT06788886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06788886 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Respiratory Therapy
Description: Participate in breathing sessions
Study NCT06789536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: training nurses to prescribe nicotine substitutes, to adapt doses and to transmit to the outpatient physician and/or nurse nurse to facilitate the continuation of treatment
Description: Nurses will undergo training sessions provided by the smoking cessation team to learn how to prescribe nicotine replacement therapy, adjust dosages, and forward a referral letter to the patient's primary care physician and/or community nurse for continuity of care. They will receive a dosage adjustment guide to share with patients. Upon completing the training, nurses will be authorized to prescribe nicotine replacement therapy using the hospital's prescription software.
Study NCT06788418 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wavelight Plus Alcon system
Description: Wavelight Plus Alcon system guided surgery for myopia
Study NCT06788418 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SMILE
Description: Small Incision Lenticule Extraction surgery for myopia
Study NCT06788418 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ICL
Description: Implantable Collamer Lens surgery for myopia
Study NCT06784700 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: Participants will be positioned inside a massage chair for a 30-min, followed by an additional 30-minute period of lying down on a proper double bed.
Study NCT06784700 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No intervention
Description: Subjects will not receive any massage program; instead, they will be rested for 30 minutes on an automatic switch-off electric massage chair and subsequently lay down for an additional 30 minutes on a proper double bed;
Study NCT06789900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus (Afinitor®)
Description: Oral dose of everolimus 5 mg once a week for 24 weeks
Study NCT06789900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Football Fitness Concept
Description: Structured hybrid exercise training via the football fitness concept organized as a super-vised group training at the University of Southern Denmark, Department of Sports Science and Clinical Biomechanics. Football Fitness concept is designed for participants with little prior experience with football and it is multifaceted training incorporating endurance training, high-intensity interval training (HIIT) and strength training. The training session lasts 60 minutes, and participants will receive two training sessions per week for 24 weeks. Each session is composed of 4 elements: a 15 min warm-up that includes strength and balance exercises, a 15 min period with technical pair-based drills, and a 30-min period with small-sided football drills
Study NCT06789315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: MMF at a dose of 750 mg twice daily for a period of 28 days,
Study NCT06789315 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Prednisone at a dose of 40 mg for 28 days.
Study NCT06789809 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Exercise MRI
Description: Exercise stress MRI with ergometer
Study NCT06790056 — intervention group
Intervention type: PROCEDURE
Intervention: duodenal ndoscopic bind ligation
Description: We will collect your basic demographics details like age, Sex, date of admission, Endoscopy (is a test to look inside your body) details of Site, size, number of lesion.~By EUS (Endoscopic ultrasound (EUS) combines two techniques - endoscopy and ultrasound - to help doctors see, evaluate and diagnose conditions in and near the gastrointestinal (GI) tract) details of layer of Duodenum involved, site/size/number of lesions.~We will collect your details of Duodenal endoscopic band ligation procedure to check feasibility, technical success.~You are requested to come for follow up for 3 months for endoscopy prodecure.
Study NCT06788509 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: JNJ-75348780
Description: Participants from the parent study (75348780LYM1001 \[NCT04540796\]) who are deriving benefit from study treatment will continue to receive subcutaneous JNJ-75348780.